Ignite Creation Date:
2025-12-24 @ 1:02 PM
Ignite Modification Date:
2026-02-02 @ 9:31 AM
Study NCT ID:
NCT03720561
Status:
COMPLETED
Last Update Posted:
2022-01-03
First Post:
2018-10-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting
Sponsor:
Janssen-Cilag S.p.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR108517
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None